265 related articles for article (PubMed ID: 15788001)
1. Neutrophil serine proteases: potential key regulators of cell signalling during inflammation.
Wiedow O; Meyer-Hoffert U
J Intern Med; 2005 Apr; 257(4):319-28. PubMed ID: 15788001
[TBL] [Abstract][Full Text] [Related]
2. More than destructive: neutrophil-derived serine proteases in cytokine bioactivity control.
Bank U; Ansorge S
J Leukoc Biol; 2001 Feb; 69(2):197-206. PubMed ID: 11272269
[TBL] [Abstract][Full Text] [Related]
3. Neutrophil elastase, proteinase 3 and cathepsin G: physicochemical properties, activity and physiopathological functions.
Korkmaz B; Moreau T; Gauthier F
Biochimie; 2008 Feb; 90(2):227-42. PubMed ID: 18021746
[TBL] [Abstract][Full Text] [Related]
4. Neutrophil-derived serine proteases modulate innate immune responses.
Meyer-Hoffert U
Front Biosci (Landmark Ed); 2009 Jan; 14(9):3409-18. PubMed ID: 19273284
[TBL] [Abstract][Full Text] [Related]
5. Neutrophil Proteases Activate Eosinophil Function in vitro.
Hiraguchi Y; Nagao M; Hosoki K; Tokuda R; Fujisawa T
Int Arch Allergy Immunol; 2008; 146 Suppl 1():16-21. PubMed ID: 18504401
[TBL] [Abstract][Full Text] [Related]
6. Neutrophil-platelet interactions in inflammation.
Selak MA
Receptor; 1994; 4(1):3-7. PubMed ID: 8038704
[TBL] [Abstract][Full Text] [Related]
7. Neutrophil serine proteases: mediators of innate immune responses.
Meyer-Hoffert U; Wiedow O
Curr Opin Hematol; 2011 Jan; 18(1):19-24. PubMed ID: 21042214
[TBL] [Abstract][Full Text] [Related]
8. Neutrophil serine proteases: specific regulators of inflammation.
Pham CT
Nat Rev Immunol; 2006 Jul; 6(7):541-50. PubMed ID: 16799473
[TBL] [Abstract][Full Text] [Related]
9. Neutrophil serine proteases fine-tune the inflammatory response.
Pham CT
Int J Biochem Cell Biol; 2008; 40(6-7):1317-33. PubMed ID: 18180196
[TBL] [Abstract][Full Text] [Related]
10. Human neutrophils kill Streptococcus pneumoniae via serine proteases.
Standish AJ; Weiser JN
J Immunol; 2009 Aug; 183(4):2602-9. PubMed ID: 19620298
[TBL] [Abstract][Full Text] [Related]
11. Serine proteases of the human immune system in health and disease.
Heutinck KM; ten Berge IJ; Hack CE; Hamann J; Rowshani AT
Mol Immunol; 2010 Jul; 47(11-12):1943-55. PubMed ID: 20537709
[TBL] [Abstract][Full Text] [Related]
12. SLPI and trappin-2 as therapeutic agents to target airway serine proteases in inflammatory lung diseases: current and future directions.
Zani ML; Tanga A; Saidi A; Serrano H; Dallet-Choisy S; Baranger K; Moreau T
Biochem Soc Trans; 2011 Oct; 39(5):1441-6. PubMed ID: 21936830
[TBL] [Abstract][Full Text] [Related]
13. Release and degradation of angiotensin I and angiotensin II from angiotensinogen by neutrophil serine proteinases.
Ramaha A; Patston PA
Arch Biochem Biophys; 2002 Jan; 397(1):77-83. PubMed ID: 11747312
[TBL] [Abstract][Full Text] [Related]
14. Evidence for a crucial role of neutrophil-derived serine proteases in the inactivation of interleukin-6 at sites of inflammation.
Bank U; Küpper B; Reinhold D; Hoffmann T; Ansorge S
FEBS Lett; 1999 Nov; 461(3):235-40. PubMed ID: 10567703
[TBL] [Abstract][Full Text] [Related]
15. Alpha-melanocyte-stimulating hormone down-regulates CXC receptors through activation of neutrophil elastase.
Manna SK; Sarkar A; Sreenivasan Y
Eur J Immunol; 2006 Mar; 36(3):754-69. PubMed ID: 16479540
[TBL] [Abstract][Full Text] [Related]
16. Natural compounds as inhibitors of human neutrophil elastase.
Siedle B; Hrenn A; Merfort I
Planta Med; 2007 May; 73(5):401-20. PubMed ID: 17447201
[TBL] [Abstract][Full Text] [Related]
17. [Serine protease inhibitors (serpins); regulators of coagulation and inflammation reactions with therapeutic potential].
Hack CE; Abbink JJ; Nuijens JH
Ned Tijdschr Geneeskd; 1990 May; 134(21):1035-9. PubMed ID: 2195358
[No Abstract] [Full Text] [Related]
18. Rapid inactivation of alpha-1-proteinase inhibitor by neutrophil specific leukolysin/membrane-type matrix metalloproteinase 6.
Nie J; Pei D
Exp Cell Res; 2004 Jun; 296(2):145-50. PubMed ID: 15149845
[TBL] [Abstract][Full Text] [Related]
19. In vivo inhibition of serine protease processing requires a high fractional inhibition of cathepsin C.
Méthot N; Guay D; Rubin J; Ethier D; Ortega K; Wong S; Normandin D; Beaulieu C; Reddy TJ; Riendeau D; Percival MD
Mol Pharmacol; 2008 Jun; 73(6):1857-65. PubMed ID: 18326050
[TBL] [Abstract][Full Text] [Related]
20. Modulation of tissue factor and tissue factor pathway inhibitor-1 by neutrophil proteases.
Steppich BA; Seitz I; Busch G; Stein A; Ott I
Thromb Haemost; 2008 Dec; 100(6):1068-75. PubMed ID: 19132232
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]